Legal & General Group’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Sell
27,418
-5,438
-17% -$395K ﹤0.01% 1856
2025
Q4
$2.48M Buy
32,856
+5,193
+19% +$327K ﹤0.01% 1890
2025
Q3
$1.1M Sell
27,663
-26
-0.1% -$993 ﹤0.01% 2213
2025
Q2
$1.2M Buy
27,689
+1,907
+7% +$72.5K ﹤0.01% 2176
2025
Q1
$963K Sell
25,782
-91
-0.4% -$3.52K ﹤0.01% 2200
2024
Q4
$1.17M Buy
25,873
+5,003
+24% +$255K ﹤0.01% 2181
2024
Q3
$1.23M Sell
20,870
-218
-1% -$10.4K ﹤0.01% 2163
2024
Q2
$830K Buy
21,088
+829
+4% +$40.2K ﹤0.01% 2254
2024
Q1
$1.35M Buy
20,259
+9,922
+96% +$433K ﹤0.01% 2088
2023
Q4
$289K Buy
10,337
+7,157
+225% +$143K ﹤0.01% 2637
2023
Q3
$67.7K Buy
+3,180
New +$70.1K ﹤0.01% 2850

Other funds holding APGE